Eagle Pharmaceuticals (EGRX) Q3 2024 Earnings

6AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
0.77
0.85
0.93
1.01

Details

Expected EPS
0.77
Actual EPS
N/A
Surprise EPS
-0.77
Surprise Percent
+100%

Description

Eagle Pharmaceuticals (EGRX) will report earnings of for Q3 2024 on August 06, 2024.

0 Comments

Share your thoughts